Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients

Immune-checkpoint inhibitors (ICIs) targeting cytotoxic T lymphocyte-associated antigen-4 and programmed cell death ligand-1) are associated with several immune-related neurological disorders. Cases of meningitis related to ICIs are poorly described in literature and probably underestimated. Several...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuzzubbo, Stefania, Tetu, Pauline, Guegan, Sarah, Ursu, Renata, Belin, Catherine, Sirven Villaros, Lila, Mazoyer, Julie, Lheure, Coralie, Lebbe, Celeste, Baroudjian, Barouyr, Carpentier, Antoine F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398097/
https://www.ncbi.nlm.nih.gov/pubmed/32747471
http://dx.doi.org/10.1136/jitc-2020-001034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398097/
https://www.ncbi.nlm.nih.gov/pubmed/32747471
http://dx.doi.org/10.1136/jitc-2020-001034

Ejemplares similares